Lasmiditan is a 5-HT1F receptor agonist utilized for the acute treatment of migraine with or without aura in adults. This category provides a comprehensive selection of reference standards, including the… Read more




































Lasmiditan is a 5-HT1F receptor agonist utilized for the acute treatment of migraine with or without aura in adults. This category provides a comprehensive selection of reference standards, including the active pharmaceutical ingredient, synthesis-related impurities, and human metabolites essential for pharmaceutical development. Laboratories employ these compounds to perform rigorous impurity profiling and method validation, ensuring the accuracy and reliability of analytical procedures. The inclusion of stable isotope labelled compounds facilitates precise mass spectrometry analysis, allowing for the quantification of the drug and its degradants in complex matrices. By maintaining access to these standardized materials, researchers and quality control professionals can effectively monitor product purity and verify that manufacturing processes consistently meet stringent regulatory requirements for this therapeutic agent.